Tirosint Capsule
Product Images NDC 71858-0012

13 FDA label images from Ibsa Pharma Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Tirosint (NDC 71858-0012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ibsa Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

As Tirosint 100 Mcg 30 Cps 499312

As Tirosint 100 Mcg 30 Cps   499312
Packaging label for Tirosint levothyroxine sodium capsules, 100 mcg per capsule, distributed by IBSA Pharma Inc. The label shows a carton design with a warning not to remove individual capsules from blister packaging until ready to use and advises swallowing the capsule whole. The package contains 3 blisters of 10 capsules each, and includes storage instructions and tamper-evident warnings.*
FDA Label Image

As Tirosint 112 Mcg 30 Cps 499322

As Tirosint 112 Mcg 30 Cps   499322
Packaging label for Tirosint 112 mcg capsules, levothyroxine sodium oral capsules by IBSA Pharma Inc. The carton shows the drug name, strength, dosage form, and quantity of 3 blisters with 10 capsules each. It includes storage instructions, tamper-evident warning, and a note to swallow capsules whole. The design features the IBSA logo and barcode.*
FDA Label Image

As Tirosint 125 Mcg 30 Cps 499332

As Tirosint 125 Mcg 30 Cps   499332
Carton label for Tirosint capsules containing 125 mcg of levothyroxine sodium per capsule. The label indicates a package of 3 blisters with 10 capsules each. It includes directions to swallow the capsule whole and a warning not to remove capsules from blister packaging until ready to use. The manufacturer is IBSA Pharma Inc., with storage instructions and a barcode also visible.*
FDA Label Image

As Tirosint 13 Mcg 30 Cps 499262

As Tirosint 13 Mcg 30 Cps   499262
Packaging label for Tirosint levothyroxine sodium capsules, 13 mcg per capsule, manufactured by IBSA Pharma Inc. The label shows 3 blisters of 10 capsules each, with storage instructions and a tamper-evident warning. The design includes dosage caution to swallow the capsule whole and not remove capsules until ready to use. Barcodes and distributor information are also visible.*
FDA Label Image

As Tirosint 137 Mcg 30 Cps 499342

As Tirosint 137 Mcg 30 Cps   499342
Packaging label for Tirosint 137 mcg levothyroxine sodium capsules. The label shows the dosage strength prominently in a blue box and specifies the capsules come in a package containing 3 blisters of 10 capsules each. The label includes storage instructions, tamper-evident warnings, and manufacturer IBSA Pharma Inc. It features the NDC 71858-0045-4 and dispensing note Rx Only.*
FDA Label Image

As Tirosint 150 Mcg 30 Cps 499352

As Tirosint 150 Mcg 30 Cps   499352
Tirosint 150 mcg capsules packaging label for oral administration, containing levothyroxine sodium. The label shows a beige box design with the IBSA logo, NDC 71858-0050-4, and dosage strength prominently displayed. Packaging is labeled Rx only and contains 3 blisters of 10 capsules each. Storage, tamper-evident, and usage cautions are included, along with manufacturer and distributor details for IBSA Pharma Inc.*
FDA Label Image

As Tirosint 175 Mcg 30 Cps 499362

As Tirosint 175 Mcg 30 Cps   499362
Packaging label for Tirosint (levothyroxine sodium) capsules, 175 mcg per capsule, with a quantity of 3 blisters x 10 capsules. The label includes dosage usage instructions, storage conditions, and tamper-evident warnings. It features the IBSA Pharma Inc. logo and contact information, along with a barcode and NDC 71858-0055-4.*
FDA Label Image

As Tirosint 200 Mcg 30 Cps 499372

As Tirosint 200 Mcg 30 Cps   499372
Packaging label for Tirosint 200 mcg capsules, containing levothyroxine sodium as the active ingredient, manufactured by IBSA Pharma Inc. The box holds 3 blisters with 10 capsules each. Key warnings include not removing individual capsules from the blister packaging until use and instructions to swallow capsules whole without cutting or crushing. Storage conditions specify controlled room temperature protection from light and moisture.*
FDA Label Image

As Tirosint 25 Mcg 30 Cps 499272

As Tirosint 25 Mcg 30 Cps   499272
Packaging label for Tirosint levothyroxine sodium capsules, 25 mcg per capsule, in an oral dosage form. The label indicates the product is prescription only, packaged as 3 blisters with 10 capsules each. The label includes storage instructions, tamper-evident warnings, and manufacturer IBSA Pharma Inc. The design features an orange box highlighting the strength and includes a barcode and NDC 71858-0010-4.*
FDA Label Image

As Tirosint 50 Mcg 30 Cps 499282

As Tirosint 50 Mcg 30 Cps   499282
TIROSINT 50 mcg capsules packaging label for levothyroxine sodium oral capsules by IBSA Pharma Inc. The label shows 50 mcg per capsule, with packaging containing 3 blisters of 10 capsules each. It includes storage instructions, tamper-evident warnings, and manufacturer and distributor details. The label also cautions not to remove capsules from blister packaging until ready to use, and to swallow capsules whole without cutting, crushing, or chewing.*
FDA Label Image

As Tirosint 75 Mcg 30 Cps 499292

As Tirosint 75 Mcg 30 Cps   499292
Tirosint 75 mcg levothyroxine sodium capsules carton packaging label. The label shows the product name, active ingredient, and strength prominently. It indicates the packaging contains 3 blisters of 10 capsules each and is for prescription use only. The label includes storage instructions, tamper-evident warnings, and the manufacturer as IBSA Pharma Inc. The label also displays barcodes and a precaution to keep drugs out of reach of children.*
FDA Label Image

As Tirosint 88 Mcg 30 Cps 499302

As Tirosint 88 Mcg 30 Cps   499302
Tirosint 88 mcg capsules packaging label for levothyroxine sodium oral capsules by IBSA Pharma Inc. The label specifies 3 blisters of 10 capsules, with instructions to swallow whole and not to remove individual capsules from blister packaging until ready to use. It includes storage conditions and tamper-evident warnings, with the IBSA logo and barcode present, as well as manufacturing and distribution details.*
FDA Label Image

Chemical Structure (Tirosint 01)

Chemical Structure (Tirosint 01)
Chemical structure of levothyroxine sodium, the active ingredient in Tirosint capsules. The diagram shows the molecular arrangement including iodine atoms, amine, carboxylate, and aromatic groups, with sodium and water of hydration specified.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.